Showing results (461-470 of 1,918) with videos related to
Sort By:
Pageof 192
Current Drug Metabolism|May 11, 2002
Biopterin analogues: novel nitric oxide synthase inhibitors with immunosuppressive actionErnst R Werner, Gabriele Werner-FelmayerCurrent Drug Metabolism|April 8, 2003
Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuriaJohn R Cashman, Kathryn Camp, Steven S Fakharzadeh, et al.Current Drug Metabolism|May 29, 2003
Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyondSteven B KoevaryCurrent Drug Metabolism|May 29, 2003
Regulation of UDP glucuronosyltransferase genesP I Mackenzie, P A Gregory, D A Gardner-Stephen, et al.Current Drug Metabolism|November 15, 2021
Theoretical Formulation Strategies towards Neutralizing Inter-individual Variability Associated with Tacrolimus Immunosuppressant Therapy: A Case Study on Nextgeneration Personalized MedicineArun Radhakrishnan, Gowthamarajan KuppusamyCurrent Drug Metabolism|March 12, 2019
Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular CarcinomaHany A Abdel Samie, Mohd Saeed, Syed Mohd Faisal, et al.Current Drug Metabolism|March 28, 2019
Herb-Drug Interactions and HepatotoxicityMohammad K Parvez, Vikas RishiCurrent Drug Metabolism|February 26, 2019
Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to TherapyAlessia Cimadamore, Marina Scarpelli, Matteo Santoni, et al.Current Drug Metabolism|August 28, 2019
Associations of CYP2A6 Gene Polymorphism with Smoking Status Among Jordanians: Gender-Related DifferencesHana M Hammad, Amer Imraish, Belal Azab, et al.Current Drug Metabolism|October 8, 2019
Current Regulatory Standpoint on Evaluating the Bioequivalence of Different Classes of Generic Drugs - Is the Evaluation in the Right Direction?Francis Micheal, Mohanlal Sayana, Balamurali Musuvathi MotialPageof 192